Interplay of somatic alterations and immune infiltration modulates response to PD-1 blockade in advanced clear cell renal cell carcinomaDavid A. Braun, Toni K. Choueiri, Yue Hou et al.|Nature Medicine|2020Cited by 1k
Tumor and immune reprogramming during immunotherapy in advanced renal cell carcinomaKevin Bi, Eliezer M. Van Allen, Meng Xiao He et al.|Cancer Cell|2021Cited by 624
A large peptidome dataset improves HLA class I epitope prediction across most of the human populationSiranush Sarkizova, Derin B. Keskin, Letitia W. Li et al.|Nature Biotechnology|2019Cited by 539
Progressive immune dysfunction with advancing disease stage in renal cell carcinomaDavid A. Braun, Catherine J. Wu, Kelly Street et al.|Cancer Cell|2021Cited by 515
Beyond conventional immune-checkpoint inhibition — novel immunotherapies for renal cell carcinomaDavid A. Braun, Toni K. Choueiri, Ziad Bakouny et al.|Nature Reviews Clinical Oncology|2021Cited by 382